Optimal treatment sequence in colorectal cancer patients with synchronous liver metastases

被引:0
作者
Kolbinger, Fiona R. [1 ,2 ,3 ]
Kirchberg, Johanna [1 ,2 ,3 ]
Weitz, Juergen [1 ,2 ,3 ]
Fritzmann, Johannes [1 ,2 ,3 ]
机构
[1] Tech Univ Dresden, Univ Klinikum, Klin & Poliklin Viszeral Thorax & Gefasschirurg, Fetscherstr 74, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Med Fak Carl Gustav Carus, Fetscherstr 74, D-01307 Dresden, Germany
[3] Natl Ctr Tumorerkrankungen NCT UCC, Dresden, Germany
关键词
Intestinal cancer; Liver metastasis; Resection; Surgical oncology; Interdisciplinary oncology; TOTAL MESORECTAL EXCISION; ADVANCED RECTAL-CANCER; SHORT-COURSE RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; NEOADJUVANT CHEMOTHERAPY; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; PRIMARY TUMOR; MANAGEMENT; SURGERY;
D O I
10.1007/s00053-022-00624-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In patients with metastatic colorectal cancer, surgical metastasectomy is currently an obligatory component of curative treatment regimens. Optimized multimodal treatment concepts and improved surgical methods have resulted in a clear improvement of the prognosis. In particular, the number or size of liver metastases is no longer decisive for deciding between a curative and a palliative concept. In the case of synchronous hepatic metastases, the resection of the primary tumor and liver metastases can be carried out either sequentially in two surgical procedures (primary first or liver first) or in one procedure (combined approach). According to the current evidence, the oncological long-term outcome does not significantly differ between the three approaches. Therefore, the treatment strategy should be selected individually, considering disease-specific factors (e.g. primary tumor location, number and location of liver metastases) and individual factors (e.g. age and comorbidities) as well as institutional expertise and resources.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 57 条
  • [1] Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  • [2] Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
    Adam, Rene
    Wicherts, Dennis A.
    de Haas, Robbert J.
    Ciacio, Oriana
    Levi, Francis
    Paule, Bernard
    Ducreux, Michel
    Azoulay, Daniel
    Bismuth, Henri
    Castaing, Denis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) : 1829 - 1835
  • [3] Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study
    Alberts, SR
    Horvath, WL
    Stcrnfeld, WC
    Goldberg, RM
    Mahoney, MR
    Dakhil, SR
    Levitt, R
    Rowland, K
    Nair, S
    Sargent, DJ
    Donohue, JH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9243 - 9249
  • [4] Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials
    Aprile, Giuseppe
    Fontanella, Caterina
    Bonotto, Marta
    Rihawi, Karim
    Lutrino, Stefania Eufemia
    Ferrari, Laura
    Casagrande, Mariaelena
    Ongaro, Elena
    Berretta, Massimiliano
    Avallone, Antonio
    Rosati, Gerardo
    Giuliani, Francesco
    Fasola, Gianpiero
    [J]. ONCOTARGET, 2015, 6 (30) : 28716 - 28730
  • [5] The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
    Ayez, N.
    van der Stok, E. P.
    Grunhagen, D. J.
    Rothbarth, J.
    van Meerten, E.
    Eggermont, A. M.
    Verhoef, C.
    [J]. EJSO, 2015, 41 (07): : 859 - 867
  • [6] Long-term Results of the "Liver First" Approach in Patients With Locally Advanced Rectal Cancer and Synchronous Liver Metastases
    Ayez, Ninos
    Burger, Jacobus W. A.
    van der Pool, Anne E.
    Eggermont, Alexander M. M.
    Grunhagen, Dirk J.
    de Wilt, Johannes H. W.
    Verhoef, Cornelis
    [J]. DISEASES OF THE COLON & RECTUM, 2013, 56 (03) : 281 - 287
  • [7] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 29 - 42
  • [8] Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - Meta-analysis
    Bipat, S
    van Leeuwen, MS
    Comans, EFI
    Pijl, MEJ
    Bossuyt, PMM
    Zwinderman, AH
    Stoker, J
    [J]. RADIOLOGY, 2005, 237 (01) : 123 - 131
  • [9] Selection of patients for resection of hepatic colorectal metastases: Expert consensus statement
    Charnsangavej, Chusilp
    Clary, Bryan
    Fong, Yuman
    Grothey, Axel
    Pawlik, Timothy M.
    Choti, Michael A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) : 1261 - 1268
  • [10] Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
    Creasy, John M.
    Sadot, Eran
    Koerkamp, Bas Groot
    Chou, Joanne F.
    Gonen, Mithat
    Kemeny, Nancy E.
    Balachandran, Vinod P.
    Kingham, T. Peter
    DeMatteo, Ronald P.
    Allen, Peter J.
    Blumgart, Leslie H.
    Jarnagin, William R.
    D'Angelica, Michael I.
    [J]. SURGERY, 2018, 163 (06) : 1238 - 1244